Cargando…
Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
BACKGROUND: Prior studies suggest that renin-angiotensin-aldosterone system (RAAS) inhibitors decrease parathyroid hormone (PTH) secretion. OBJECTIVE: To evaluate the effect of angiotensin-converting enzyme inhibitors (ACEi) on serum PTH in participants with and without primary hyperparathyroidism (...
Autores principales: | Zaheer, Sarah, Brown, Jenifer M., Connors, Molly, Williams, Jonathan S., Adler, Gail K., Vaidya, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541811/ https://www.ncbi.nlm.nih.gov/pubmed/28808443 http://dx.doi.org/10.1155/2017/4138783 |
Ejemplares similares
-
A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes
por: Zaheer, Sarah, et al.
Publicado: (2018) -
Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study
por: Brown, Jenifer M, et al.
Publicado: (2013) -
Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021) -
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
por: Aggarwal, Neerja, et al.
Publicado: (2017) -
Syndrome of inappropriate secretion of antidiuretic hormone
associated with angiotensin-converting enzyme inhibitor therapy in the
perioperative period
por: Nakayama, Takashin, et al.
Publicado: (2019)